Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.

Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.
复制标题

β干扰素增强了神经炎症性疾病中白细胞介素 - 23驱动的辅助性T细胞的致病性。

DOI:
10.3390/cells10082139
复制
发表时间:
2021-08-20
期刊:
影响因子:
6
通讯作者:
Axtell RC
Axtell RC
中科院分区:
生物学2区
文献类型:
--
作者:
Agasing A;Quinn JL;Kumar G;Axtell RC

文献摘要

参考文献

被引文献

相似文献

干扰素(IFN)-β是多发性硬化(MS)的常用疗法。然而,25-40%的患者对这种疗法无反应,这是另一种神经炎性疾病-视神经肌萎缩症(NMO)。我们先前在NMO患者和小鼠中鉴定了IFN-β治疗通过产生炎性细胞因子IL-6在T辅助细胞(TH)17诱导的疾病中具有炎性作用。然而,其他研究表明IFN-β抑制TH 17细胞的分化和功能。在这份手稿中,我们确定了IFN-β对TH 17发育的离散阶段具有不同的影响。在早期TH 17发育过程中,IFN-β抑制IL-17的产生。相反,在晚期TH 17分化期间,IFN-β与IL-23协同作用以促进具有TH 1和TH 17特征并表达升高水平的强效炎性细胞因子IL-6和GM-CSF以及转录因子BLIMP的致病性T细胞。总之,这些发现有助于解决围绕IFN-β和TH 17诱导的疾病的矛盾,并阐明了负责NMO和MS患者的病理生理学的途径,这些患者是IFN-β无应答者。
Interferon (IFN)-β is a popular therapy for multiple sclerosis (MS). However, 25–40% of patients are nonresponsive to this therapy, and it worsens neuromyelitis optica (NMO), another neuroinflammatory disease. We previously identified, in both NMO patients and in mice, that IFN-β treatment had inflammatory effects in T Helper (TH) 17-induced disease through the production of the inflammatory cytokine IL-6. However, other studies have shown that IFN-β inhibits the differentiation and function of TH17 cells. In this manuscript, we identified that IFN-β had differential effects on discrete stages of TH17 development. During early TH17 development, IFN-β inhibits IL-17 production. Conversely, during late TH17 differentiation, IFN-β synergizes with IL-23 to promote a pathogenic T cell that has both TH1 and TH17 characteristics and expresses elevated levels of the potent inflammatory cytokines IL-6 and GM-CSF and the transcription factor BLIMP. Together, these findings help resolve a paradox surrounding IFN-β and TH17-induced disease and illuminate the pathways responsible for the pathophysiology of NMO and MS patients who are IFN-β nonresponders.
DOI: 10.1371/journal.pone.0061835
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Matsushita T;Tateishi T;Isobe N;Yonekawa T;Yamasaki R;Matsuse D;Murai H;Kira J
通讯作者: Kira J
DOI: 10.1016/j.cell.2006.07.035
发表时间: 2006-09-22
期刊: CELL
影响因子: 64.5
作者:
Ivanov, Ivaylo I.;McKenzie, Brent S.;Littman, Dan R.
通讯作者: Littman, Dan R.
DOI: 10.1016/j.immuni.2006.01.001
发表时间: 2006-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Veldhoen, M;Hocking, RJ;Stockinger, B
通讯作者: Stockinger, B
DOI: 10.1001/jamaneurol.2013.192
发表时间: 2013-08-01
期刊: JAMA NEUROLOGY
影响因子: 29
作者:
Hartung, Hans-Peter;Steinman, Lawrence;Pohl, Christopher
通讯作者: Pohl, Christopher
DOI: 10.4049/jimmunol.174.2.609
发表时间: 2005-01-15
影响因子: 4.4
作者:
Tanabe, Y;Nishibori, T;David, M
通讯作者: David, M